MS Franchise is Screwed

Genentech's Ocrelizumab was just approved AND they priced it 25% lower than Aubagio, or Lemtrada. Efficacy was as good as Lemtrada and their PI was almost the ideal case in terms of safety content.

Genzyme's MS franchise has long been a joke run by untalented people who don't work hard. Was only saved by over-promise blowback from Tecfidera plateau'ing. Aubagio is still barely better than a placebo sugar pill, in terms of efficacy, and nobody wants all the side effects of Lemtrada

 

aub side effects are terrible. Only reason it's gaining a lil traction is pml hasn't been an issue like the other two orals. Otherwise, it's efficacy is like a platform, with pregnancy issues, hairloss, liver concerns, and doesn't do much for cutting relapses.

 

Not to mention the goofball NR they put in charge of the Sales Force. How desperate were they?

 

Genzyme MS is about to fold like a house of cards

 

Looks like Biogen reps upset Aubagio is taking share away them

 

How is the BRM role? Appears to be a great gig with a good Quality of Life component!

 

used to be a good role, not so much anymore..

 

Well your no PML story is over kids. Poster being done at ECTRIMS will show what a toxic, poor efficacy, crap product Aubagio truly is..... can't blame Tysabri seeing the titters were so low.

 

I'm surprised Aubagio was even strong enough to cause PML. What a turd of a drug

 

Last remaining MS rep turn out the lights.

 

This thread is truly silly. Here we are 2 years later stronger than ever- even in light of new competitors. Both products are truly unique and not going anywhere.

 

Can anyone share any information on the NYC position...manager, salary, goal expectations?

 

Is Mavenclad putting Lemtrada finally 6 feet under?

 

Not Mavenclad, but it’s own safety profile. If you sell Lemtrada, it’s a good time to dust off the resume. Covid speeding up its end.